(上皮样肉瘤。免疫组织化学研究。重组α干扰素治疗]。

Q4 Medicine

Medicina cutanea ibero-latino-americana Pub Date : 1990-01-01

J Porta, R Azcune, A E Ardura, A Arra, C F Gatti

{"title":"(上皮样肉瘤。免疫组织化学研究。重组α干扰素治疗]。","authors":"J Porta, R Azcune, A E Ardura, A Arra, C F Gatti","doi":"","DOIUrl":null,"url":null,"abstract":"A case of Epithelioid Sarcoma in a 26 years old woman is reported. Clinical aspects of this entity are commented. Immunomarcation with monoclonal and policlonal antibodies was made, the findings were compared to those of the literature. Supervivence of the patient for 6 years without agressive surgery is remarked. Treatment was ruled out with recombinant alfa interferon for the last 3 years.","PeriodicalId":18373,"journal":{"name":"Medicina cutanea ibero-latino-americana","volume":"18 3","pages":"191-6"},"PeriodicalIF":0.0000,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Epithelioid sarcoma. Immunohistochemical study. Therapy with recombinant alfa interferon].\",\"authors\":\"J Porta, R Azcune, A E Ardura, A Arra, C F Gatti\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A case of Epithelioid Sarcoma in a 26 years old woman is reported. Clinical aspects of this entity are commented. Immunomarcation with monoclonal and policlonal antibodies was made, the findings were compared to those of the literature. Supervivence of the patient for 6 years without agressive surgery is remarked. Treatment was ruled out with recombinant alfa interferon for the last 3 years.\",\"PeriodicalId\":18373,\"journal\":{\"name\":\"Medicina cutanea ibero-latino-americana\",\"volume\":\"18 3\",\"pages\":\"191-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1990-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicina cutanea ibero-latino-americana\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina cutanea ibero-latino-americana","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

本文报告一例26岁女性上皮样肉瘤。对该实体的临床方面进行了评论。用单克隆抗体和单克隆抗体进行免疫标记，并与文献结果进行比较。患者随访6年，未行积极手术。在过去的3年里，排除了重组α干扰素的治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

[Epithelioid sarcoma. Immunohistochemical study. Therapy with recombinant alfa interferon].

A case of Epithelioid Sarcoma in a 26 years old woman is reported. Clinical aspects of this entity are commented. Immunomarcation with monoclonal and policlonal antibodies was made, the findings were compared to those of the literature. Supervivence of the patient for 6 years without agressive surgery is remarked. Treatment was ruled out with recombinant alfa interferon for the last 3 years.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Medicina cutanea ibero-latino-americana Medicine-Dermatology

自引率

0.00%

发文量

期刊介绍： La Revista Medicina Cutánea Ibero-Latino-Americana se adhiere a los “Requisitos de uniformidad para manuscritos presentados para publicación en revista biomédicas” elaborados por el Comité Internacional de Editores de Revista Médicas